Liver	liver	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
caused	caused	O	O	O	O
by	by	O	O	O	O
propylthiouracil	propylthiouracil	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

This	this	O	O	O	O
report	report	O	O	O	O
presents	presents	O	O	O	O
the	the	O	O	O	O
clinical	clinical	O	O	O	O
,	,	O	O	O	O
laboratory	laboratory	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
light	light	O	O	O	O
and	and	O	O	O	O
electron	electron	O	O	O	O
microscopic	microscopic	O	O	O	O
observations	observations	O	O	O	O
on	on	O	O	O	O
a	a	O	O	O	O
patient	patient	O	O	O	O
with	with	O	O	O	O
chronic	chronic	O	O	OTHERS	I
active	active	O	O	OTHERS	I
(	(	O	O	OTHERS	I
aggressive	aggressive	O	O	OTHERS	I
)	)	O	O	OTHERS	I
hepatitis	hepatitis	O	DISEASE	OTHERS	I
caused	caused	O	O	O	O
by	by	O	O	O	O
the	the	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
propylthiouracil	propylthiouracil	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

This	this	O	O	O	O
is	is	O	O	O	O
an	an	O	O	O	O
addition	addition	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
list	list	O	O	O	O
of	of	O	O	O	O
drugs	drugs	O	O	O	O
that	that	O	O	O	O
must	must	O	O	O	O
be	be	O	O	O	O
considered	considered	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
evaluation	evaluation	O	O	O	O
of	of	O	O	O	O
chronic	chronic	O	O	OTHERS	I
liver	liver	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
.	.	O	O	O	O

